Related Experiment Video
Updated: Jun 20, 2026

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
Published on: November 23, 2017
Green tea polyphenols inhibit plasminogen activator inhibitor-1 expression and secretion in endothelial cells
Jian Liu1, Chenjiang Ying, Yi Meng
1Department of Nutrition and Food Hygiene, School of Public Health, PR China.
Insights
Green tea polyphenols (GTPs) reduce plasminogen activator inhibitor-1 (PAI-1) in endothelial cells. This pathway may offer cardiovascular protection by inhibiting PAI-1 expression and secretion.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Nutritional Science
Background:
- Epidemiological studies link green tea consumption to reduced cardiovascular disease risk.
- Plasminogen activator inhibitor-1 (PAI-1) is implicated in cardiovascular conditions like arteriosclerosis and hypertension.
- Elevated PAI-1 levels are associated with atherosclerotic lesions and coronary heart disease.
Purpose of the Study:
- To investigate the effect of green tea polyphenols (GTPs) on PAI-1 expression in endothelial cells.
- To elucidate the molecular mechanisms underlying GTPs' regulation of PAI-1.
- To assess the potential of GTPs in cardiovascular disease prevention.
Main Methods:
- Bovine aortic endothelial cells were treated with varying concentrations and durations of GTPs.
- PAI-1 expression and secretion were quantified using Western blot and ELISA.
- The role of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway was examined using wortmannin and Akt activation assays.
Main Results:
- GTPs significantly decreased PAI-1 expression and secretion in a dose- and time-dependent manner.
- Inhibition of PI3K with wortmannin reversed the suppressive effect of GTPs on PAI-1.
- GTP treatment led to increased activation of the protein kinase Akt.
Conclusions:
- GTPs inhibit PAI-1 expression and secretion in endothelial cells via the PI3K/Akt signaling pathway.
- This mechanism suggests a potential role for GTPs in cardiovascular protection.
- Green tea consumption may contribute to managing cardiovascular health by modulating PAI-1 levels.
Abstract:
Compelling epidemiological evidence suggests that the consumption of green tea is associated with beneficial effects in prevention of cardiovascular diseases. Plasminogen activator inhibitor-1 (PAI-1) is known to play a pivotal role in cardiovascular diseases including arteriosclerosis and hypertension. Increased PAI-1 was found in atherosclerotic lesions, and high PAI-1 plasma levels were associated with coronary heart disease. To determine the effect and molecular mechanism of green tea polyphenols (GTPs) on the regulation of PAI-1 expression in endothelial cells, bovine aortic endothelial cells were incubated with GTPs, and PAI-1 expressions were measured by western blot and enzyme-linked immunosorbent assay, respectively. GTPs significantly reduced PAI-1 expression and secretion in a time-dependent and dose-dependent manner. Inhibition of phosphatidylinositol 3-kinase (PI3K) with wortmannin markedly reversed GTPs repression of PAI-1 expression. In addition, the GTP-induced inhibitory effect was associated with an increased of activation of the protein kinase Akt. These results suggest that GTPs inhibit PAI-1 expression and its release from endothelial cells through the PI3K/Akt pathway, which may contribute to cardiovascular protection.
More Related Videos
12:00Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
07:13Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
Related Concept Videos
Clot Retraction and Fibrinolysis
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Enzyme Inhibition